FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
We have now added a new section called the "Assay History List" to the "At A Gla...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...